Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04966520
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-05
First Post:
2021-06-10
Brief Title:
Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy
Sponsor:
Sneha Phadke
Organization:
University of Iowa
Study Overview
Official Title:
Repetitive Intermittent Accelerated Theta-burst Transcranial StimulationiTBS as a Potential Intervention for Chemotherapy Induced Cognitive Deficits CICD- a Pilot Clinical Trial to Explore Feasibility and Efficacy
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project is aimed at the discovery of neuro-modulation techniques that may alleviate chemotherapy induced cognitive deficits CICD especially in executive higher-order cognitive function EF
Detailed Description:
The specific aim for this study is to use magnetic resonance spectroscopy MRS self-report and neuropsychological testing to identify changes in brain metabolite concentrationsratios and changes in EF deficits associated with chemotherapy before and after accelerated theta-burst transcranial stimulation iTBS The secondary aim is to assess for any association of changes in executive function with brain metabolite concentrations
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None